Michael Barbella, Managing Editor01.05.23
Backed by Khosla Ventures and Ycombinator, SiPhox Health is leveraging silicon photonic chips to make diagnostics 100 times faster, smaller, and less expensive—without sacrificing quality.
At this year's Consumer Electronics Show (CES), the company unveiled The SiPhox Home, which is designed to measure a range of immunoassays for key biomarkers of inflammation, metabolism, hormonal, and heart health in a single sample. The platform requires less than a drop of blood, delivers results in under five minutes and has been externally validated against traditional central lab methods.
"Silicon Photonics has revolutionized the way internet data is transmitted, creating the modern world of Zoom and constant connectivity," SiPhox CoFounder Diedrik Vermeulen said. "SiPhox has applied this powerful semiconductor platform to enable testing that is 100x smaller, faster, and cheaper than anything out there - without sacrificing any quality or accuracy."
SiPhox is conducting live testing and demonstrations at CES (booth #61314, Las Vegas) through Jan. 7.
The SiPhox Home has not been evaluated by the U.S. Food and Drug Administration and is limited by U.S. law to investigational use.
At this year's Consumer Electronics Show (CES), the company unveiled The SiPhox Home, which is designed to measure a range of immunoassays for key biomarkers of inflammation, metabolism, hormonal, and heart health in a single sample. The platform requires less than a drop of blood, delivers results in under five minutes and has been externally validated against traditional central lab methods.
"Silicon Photonics has revolutionized the way internet data is transmitted, creating the modern world of Zoom and constant connectivity," SiPhox CoFounder Diedrik Vermeulen said. "SiPhox has applied this powerful semiconductor platform to enable testing that is 100x smaller, faster, and cheaper than anything out there - without sacrificing any quality or accuracy."
SiPhox is conducting live testing and demonstrations at CES (booth #61314, Las Vegas) through Jan. 7.
The SiPhox Home has not been evaluated by the U.S. Food and Drug Administration and is limited by U.S. law to investigational use.